Moderna's new corona vaccine is priced too high and won the disgraceful 'Sukurelli Award'



The new coronavirus vaccine developed by American biotechnology company

Moderna has shown 94.1% efficacy in clinical trials and has been approved for use not only in the United States but also in the EU. However, Moderna's vaccine has won the 'Shkreli Award', a disgraceful award in the healthcare field, for 'setting a price that is too high compared to other new coronavirus vaccines'. rice field.

2020 Shkreli Awards --Lown Institute
https://lowninstitute.org/projects/shkreli-awards/2020-shkreli-awards/

“Shkreli Award” goes to Moderna for “blatantly greedy” COVID vaccine prices | Ars Technica
https://arstechnica.com/science/2021/01/moderna-shamed-with-shkreli-award-over-high-covid-vaccine-prices/

The Sucreli Award is a disgraceful award presented by the Loan Institute , a healthcare think tank, and is given to 'the most vicious perpetrators of profitability and dysfunction in the healthcare sector.' The name 'Shkreli' is named after Martin Shkreli , a former director of a pharmaceutical company.

In 2015, Mr. Sukreri acquired the manufacturing right for a drug called Dalaprim, which is prescribed to AIDS patients, and raised the price per tablet from $ 13.5 (about 1400 yen) to $ 750 (about 77,000 yen) 56 times. He bought a big backlash from the world and was also called 'America's most hated man'. After that, he was charged with securities fraud and was convicted of seven years in prison, and he is still in prison at the time of writing the article.



The judges of the award point out that 'Moderna's vaccine price is too high compared to other vaccines' as to why the globally anticipated Moderna vaccine has won the disgraceful Sucreli Award. I am.

In developing the vaccine, the

Biomedical Advanced Research and Development Agency (BARDA) in the United States has provided Moderna with a total of nearly $ 1 billion , and 100% of the development cost is covered by the funds of the US government. In August 2020, when vaccine development was nearing success, Moderna set the cost of vaccination at $ 32-37 per vaccination. Since the new coronavirus vaccine needs to be given twice, the cost per person will be doubled.

On the other hand, Pfizer and BioNTech, which were also developing vaccines, will raise the vaccine price per vaccine to $ 19.5 (about 2000 yen) and $ 39 (about 4000 yen) for two vaccinations with the US government. With a contract, Johnson & Johnson had set the cost of the vaccine at $ 10 each. Pfizer and BioNTech are developing vaccines mainly with the support of the German government and the European Investment Bank, and are not supported by the US government.

The criticized Moderna lowered the vaccine price and eventually signed a contract with the US government to offer a total price of two doses for $ 30. However, the judges said, 'The vaccine is ours because we, the people, are funding the development of this vaccine. It must be provided free of charge to all Americans.' 'Moderna's vaccine price Is like taxing us twice, 'he said, claiming that Moderna's vaccine prices are unreasonably high even after the price cuts.



In addition to the Moderna vaccine, the topics that won the 2020 'Sukureri Award' are as follows.

◆: Medical staff dispatch companies 'Team Health' and 'Envision'
These companies have cut salaries and allowances for frontline clinicians during the pandemic and spent millions of dollars on political advertising.

◆: Jim Bakker, a fraudulent religious evangelist
Jim Baker of religious evangelist, which may also be convicted as crooks, as false the new coronavirus infection during the pandemic period (COVID-19) treatment oleanders a profit selling of the extract In addition, some doctors have sold unfounded remedies and treatment sets.

◆: Connecticut doctor Steven Murphy
Connecticut doctor Murphy conducted a panel test on 20 different pathogens in addition to the new coronavirus to visitors to a public coronavirus testing facility. Mr. Murphy, who over-tested, said that he charged $ 2,000 (about 210,000 yen) per person through an insurance company.

◆: A hospital that dismissed a clinician over wearing a mask
In the early days of the pandemic, doctors claiming to wear N-95 masks and other protective equipment were forced to suspend or be dismissed at several hospitals in the United States. For this reason, the hospital justified its actions, saying that 'wearing N-95 masks and other protective equipment unnecessarily scares patients.'

◆: CEO of the hospital who did not disclose conflicts of interest regarding vaccines
Dr. Elizabeth Nebel, CEO of Brigham and Women's Hospital, wrote an editorial in February 2020, early in the pandemic, stating that 'it is necessary to raise drug prices for innovation.' At the time, Dr. Nebel was a member of the board of Moderna, who was developing the vaccine, but did not disclose this in his editorial. After that, Dr. Nebel sold the shares of Moderna, which had quadrupled due to the success of vaccine development, and made a profit of 8.5 million dollars (about 870 million yen).



◆: A major pharmaceutical company competing in drug development
The Lone Institute has accused major pharmaceutical companies such as Pfizer, Atlas Zeneca, GlaxoSmithKline, and Johnson & Johnson of not cooperating in the development of new coronavirus-related drugs. These companies did not participate in the development of new coronavirus-related drugs, denying the World Health Organization (WHO) -led initiative called 'C-TAP,' which shares test data and patent rights information.

◆: Elderly housing with vulnerable infectious diseases
Elderly housing with care has become a major cluster of the new coronavirus in the United States, and due to insufficient staffing and lack of infectious disease control, more than 100,000 residents and staff will be COVID- by the end of November 2020. Died at 19.

◆: Hospitals that did not accept uninsured patients
Four major hospitals in California have refused to accept COVID-19 patients with uninsured or insurance-related problems from hospitals where other beds have reached their limits.

◆: Federal Emergency Management Agency Personal Protective Equipment Distribution Task Force
The Federal Emergency Management Agency's Personal Protective Equipment Distribution Task Force was responsible for procuring personal protective equipment from abroad and quickly distributing it within the United States. However, it has been accused of providing protective equipment to six private drug suppliers at the distribution stage, causing bid competition between medical institutions.



in Note, Posted by log1h_ik